首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Establishment of patient-derived xenografts (PDX) models for triple negative breast cancer (TNBC) as a pre-clinical platform for drug development

【24h】

Establishment of patient-derived xenografts (PDX) models for triple negative breast cancer (TNBC) as a pre-clinical platform for drug development

机译：建立三阴性乳腺癌（TNBC）的患者源异种移植（PDX）模型作为药物开发的临床前平台

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2014年第6期|共1页
作者
Thatte J.; Meza M.; Ricono J.; Broudy T.; Mirsaidi C.; Nair P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Establishment of patient-derived xenografts (PDX) models for triple negative breast cancer (TNBC) as a pre-clinical platform for drug development [J] . Thatte J., Meza M., Ricono J., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：建立三阴性乳腺癌（TNBC）的患者源异种移植（PDX）模型作为药物开发的临床前平台
2. Establishment of patient-derived xenografts (PDX) models for small cell lung (SCL) as a pre-clinical platform for drug development [J] . Broudy T., Ricono J., Mullins C., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：建立小细胞肺（SCL）的患者来源异种移植（PDX）模型作为药物开发的临床前平台
3. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer [J] . Emily Powell, Jiansu Shao, Yuan Yuan, Breast Cancer Research . 2016,第1期

机译：与B细胞易位基因2（BTG2）损失相关的P53缺乏通过促进三重阴性乳腺癌的患者衍生的异种移植物（PDX）模型中的原发性和转移位点肿瘤生长增强转移性潜力
4. Effect of curcumin on NF-κB P105/50 expression on triple-negative breast cancer (TNBC) and its possible mechanism of action [C] . Retno Murwanti, Eva Kholifah, B. S. Ari Sudarmanto, International Conference on Biological Science . 2020

机译：姜黄素对三重阴性乳腺癌（TNBC）对NF-κBP105/ 50表达的影响及其动作机制
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer [O] . Emily Powell, Jiansu Shao, Yuan Yuan, 2016

机译：与B细胞易位基因2（BTG2）丢失有关的p53缺乏症通过促进三阴性乳腺癌患者源性异种移植（PDX）模型中原发和转移部位的肿瘤生长来增强转移潜力
7. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer [O] . 2016

机译：与B细胞易位基因2（BTG2）丢失有关的p53缺乏症通过促进三阴性乳腺癌患者源性异种移植（PDX）模型中原发和转移部位的肿瘤生长来增强转移潜力

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号